Journal of Diabetes Research / 2013 / Article / Fig 4

Research Article

Effects of Long-Term Treatment with Ranirestat, a Potent Aldose Reductase Inhibitor, on Diabetic Cataract and Neuropathy in Spontaneously Diabetic Torii Rats

Figure 4

The total cataract scores at 15 weeks. The total cataract score of the untreated SDT rats at 15 weeks is significantly higher than that of the SD rats. , Wilcoxon rank sum test. The total cataract score of the SDT rats treated with ranirestat at 15 weeks is significantly lower than that of the untreated SDT rats. , Wilcoxon rank sum test. There is no significant difference in the total cataract score between the untreated SDT rats and the SDT rats treated with epalrestat. NDM: non-diabetes mellitus; DM: diabetes mellitus; rani: ranirestat; epa: epalrestat.
175901.fig.004

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.